PTK2 and neoplasm: While we observed that FAK inhibition could reduce B16F10 tumor growth, it still remains to be seen if FAK-I-mediated loss of CDK4/6 protein increases PD-L1 expression in B16F10 cells and could eventually lead to escape from the immune system.